BPW
PFE icon

Bingham Private Wealth’s Pfizer PFE Stock Holding History

Bingham Private Wealth’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$519K Buy
18,480
+4,800
+35% +$128K 0.41% 75
2025
Q4 		$341K Buy
+13,680
New +$345K 0.29% 102
2025
Q2 		$343K Sell
14,152
-547
-4% -$12.8K 0.33% 95
2025
Q1 		$372K Buy
14,699
+4,592
+45% +$120K 0.39% 85
2024
Q4 		$268K Buy
+10,107
New +$274K 0.29% 111

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bingham Private Wealth's PFE Position: Q1 2026 in Review

Bingham Private Wealth increased its Pfizer (PFE) stake by 35% in Q1 2026, buying an estimated $128K and bringing the position to 18,480 shares worth $519K. The position accounts for 0.41% of the portfolio, ranked #75.

Bingham Private Wealth first reported a position in PFE in Q4 2024 and has held it in 5 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Bingham Private Wealth held 18,480 shares of Pfizer worth $519K as of Q1 2026.
  • Bingham Private Wealth bought 4,800 Pfizer shares in Q1 2026, an estimated $128K.
  • Pfizer made up 0.41% of Bingham Private Wealth's portfolio in Q1 2026, its #75 holding.
  • Bingham Private Wealth first reported a position in Pfizer in Q4 2024 and has held it in 5 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Bingham Private Wealth's 13F filing for Q1 2026, filed 7 May 2026.